Alchemix EP 575 White

Hazard statements (CLP)

H314, H317, H318, H341, H360F, H411

Code

Statements

H314

Causes severe skin burns and eye damage

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

Suspected of causing genetic defects. May damage fertility or the unborn child. Causes severe skin burns and eye damage. May cause an allergic skin reaction. Causes serious eye damage. Toxic to aquatic life with long lasting effects.

2.2 Label elements

Labelling

Hazard pictograms

GHS05 GHS07 GHS08 GHS09

Signal word

Danger

Contains

Formaldehyde, oligomeric reaction products with 1-chloro-2,3-epoxypropane and phenol/BPFDGE; bis-[4-(2,3-epoxipropoxi)phenyl]propane; Reaction mass of 1-(2,3- epoxypropoxy)-2,2-bis ((2,3-epoxypropoxy)methyl) butane and 1-(2,3-epoxypropoxy)-2- ((2,3-epoxypropoxy)methyl)-2-hydroxymethyl butane; Phenol polymer with formaldehyde, glycidyl ether; oxirane, mono[(C12-14-alkyloxy)methyl] derivs.

Hazard statements

H314 - Causes severe skin burns and eye damage. H317 - May cause an allergic skin reaction. H341 - Suspected of causing genetic defects. H360F - May damage fertility. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

P201 - Obtain special instructions before use. P280 - Wear protective gloves, protective clothing, eye protection. P303+P361+P353+P310 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower. Immediately call a POISON CENTER or doctor. P305+P351+P338+P310 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. P308+P313 - IF exposed or concerned: Get medical advice/attention. P321 - Specific treatment (see supplemental first aid instruction on this label).

Supplemental label elements

EUH211 - Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in bis-[4-(2,3-epoxipropoxi)phenyl]propane (1675-54-3) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605